Net loss for the period (USD, thousands)

Depreciation, amortization and accrued contingencies (USD, thousands)

Expenses related to share-based payments (USD, thousands)

Other elements (USD, thousands)

Decrease (increase) in other current assets (USD, thousands)

(Decrease) increase in trade payables (USD, thousands)

(Decrease) increase in other current and non-current liabilities (USD, thousands)

Change in operating lease liabilities and right of use assets (USD, thousands)

Net cash flow provided by (used in) operating activities (USD, thousands)

Change in property, plant, and equipment (USD, thousands)

Net cash flows provided by (used in) investing activities (USD, thousands)

Net cash flows provided by financing activities (USD, thousands)

Effect of exchange rate changes on cash and cash equivalents (USD, thousands)

Net increase (decrease) in cash and cash equivalents (USD, thousands)

Treasury shares (USD, thousands)

Net Cash and cash equivalents at the beginning of the period (USD, thousands)

Net cash and cash equivalents at the end of the period (USD, thousands)

e6defc2f2914475fa65a44b1ef43177982be6b5c3c34609ce9bb4b4b47991127

Number of full-time employees recruited in Medical, Quality and Regulatory Affairs (count)

2c11a0eff675f0418f21af18d4cace81c29b31961b3d0603bf6543aa17a63954

Operating income (USD, thousands)

Research and development expenses (USD, thousands)

Sales and marketing expenses (USD, thousands)

General and administrative expenses (USD, thousands)

Total Operating expenses (USD, thousands)

Loss from operations (USD, thousands)

Financial income (expense) (USD, thousands)

Loss before taxes (USD, thousands)

Income tax (expense) (USD, thousands)

Net loss (USD, thousands)

Foreign currency translation differences, net of taxes (USD, thousands)

Actuarial gains (losses) on employee benefits, net of taxes (USD, thousands)

Comprehensive loss (USD, thousands)

Basic/diluted Net loss per share attributable to shareholders (USD)

Weighted average shares outstanding used in computing per share amounts

d4746f3c9bc5ab984b4ae0a7dde2d9595de95d7093c93ad8a8cf33f7bb6d519b

Research Tax Credit

Other Operating Income

Total Revenue

b4116df73c168bbce0a70ae15ec9797894b4a28f2db82012ad4d9c737223e2e1

Operating Income

- French Research Tax Credit

- Other Operating Income

ee83460b28fd7072007500ed91a98c5facac98026fb4f3dbbe785bc43829c1e6

Cash and cash equivalents (USD, thousands)

Other current assets (USD, thousands)

Total current assets (USD, thousands)

Property, plant, and equipment, net (USD, thousands)

Right-of-use assets related to operating leases (USD, thousands)

Intangible assets (USD, thousands)

Other non-current assets (USD, thousands)

Total non-current assets (USD, thousands)

Total Assets (USD, thousands)

Trade payables (USD, thousands)

Short-term operating leases (USD, thousands)

Current contingencies (USD, thousands)

Other current liabilities (USD, thousands)

Total current liabilities (USD, thousands)

Long-term operating leases (USD, thousands)

Non-current contingencies (USD, thousands)

Other non-current liabilities (USD, thousands)

Total non-current liabilities (USD, thousands)

Total Liabilities (USD, thousands)

Ordinary Shares (USD, thousands)

Additional paid-in capital (USD, thousands)

Treasury Stock (USD, thousands)

Accumulated deficit (USD, thousands)

Accumulated other comprehensive income (USD, thousands)

Accumulated currency translation effect (USD, thousands)

Total Shareholders’ equity (USD, thousands)

Total Liabilities and Shareholder's equity (USD, thousands)

aa93974cee9f20e650bd7229d9a6855e30f943a243c912a9ffd18bbc73fce83b

Dbv Technologies SA (DBVT)

Financials